TELA
TELA Bio, Inc.
$0.89
+0.11 (+13.74%)
At close · Jul 7
Market Cap
$40.01M
Shares
44,766,146
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$80.28M
+15.8%
FY2025
Net Income
-$38.83M
-2.6%
FY2025
Gross Margin
67.69%
+0.6pp
FY2025
Operating Margin
-42.05%
+7.2pp
FY2025
Diluted EPS
-$0.83
+37.6%
FY2025
Operating Cash Flow
-$28.22M
+32.2%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $80.81M | $80.28M | $69.3M | $58.45M | $41.42M | $29.46M | $18.21M | $15.45M | $8.27M | $4.25M | |
| $54.35M | $54.34M | $46.49M | $40.11M | $27.04M | $18.81M | $11.23M | $9.27M | $2.94M | $2.53M | |
| — | 67.69% | 67.08% | 68.62% | 65.3% | 63.85% | 61.68% | 60.03% | 35.56% | 59.65% | |
| $9.02M | $9.22M | $8.81M | $9.62M | $8.94M | $6.74M | $4.26M | $4.15M | $4.34M | $5.79M | |
| $63.11M | $63.18M | $64.65M | $59.68M | $43.25M | $29.06M | $22.11M | $18.06M | $13.65M | $8.71M | |
| $16.02M | $15.69M | $14.72M | $14.89M | $13.86M | $12.46M | $10.14M | $6.22M | $4.9M | $4.96M | |
| $88.16M | $88.1M | $88.18M | $84.19M | $66.05M | $48.26M | $36.51M | $28.43M | $20.72M | $19.46M | |
| -$33.81M | -$33.76M | -$34.12M | -$44.08M | -$39.01M | -$29.45M | -$25.28M | -$19.16M | -$17.78M | -$16.92M | |
| — | -42.05% | -49.23% | -75.4% | -94.18% | -99.96% | -138.77% | -124.06% | -214.91% | -398.68% | |
| $6.08M | $5.25M | $5.29M | $5.22M | $4.05M | $3.6M | $3.56M | $3.61M | $1.8M | $4.56M | |
| -$5.79M | -$4.85M | -$3.87M | -$2.59M | -$5.29M | -$3.83M | -$3.52M | -$3.26M | -$3.31M | -$4.41M | |
| -$39.6M | -$38.6M | -$37.99M | -$46.66M | -$44.3M | — | — | — | — | — | |
| — | $230K | -$144K | — | — | — | — | — | — | — | |
| -$39.84M | -$38.83M | -$37.84M | -$46.66M | -$44.3M | -$33.28M | -$28.79M | -$22.43M | -$21.09M | -$21.33M | |
| — | -48.37% | -54.6% | -79.83% | -106.95% | -112.94% | -158.1% | -145.18% | -254.92% | -502.57% | |
| — | — | — | — | — | -$33.28M | -$28.79M | -$30.21M | -$29.92M | -$27.23M | |
| -$39.85M | -$38.83M | -$37.84M | -$46.72M | -$44.09M | -$33.26M | -$28.85M | -$22.44M | -$21.09M | -$21.33M | |
| USD/shares | — | -$0.83 | -$1.33 | -$2.04 | -$2.72 | -$2.30 | -$2.23 | -$17.10 | — | — |
| USD/shares | — | -$0.83 | -$1.33 | -$2.04 | -$2.72 | -$2.30 | -$2.23 | -$17.10 | — | — |
| shares | — | 46.95M | 28.53M | 22.87M | 16.27M | 14.47M | 12.93M | 1.77M | 294.99K | 291.96K |
| shares | — | 46.95M | 28.53M | 22.87M | 16.27M | 14.47M | 12.93M | 1.77M | 294.99K | 291.96K |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Single Reportable Segment | $80,275,000 | $69,300,000 | $58,453,000 | $41,418,000 |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Non Us | $12,100,000 | $10,300,000 | $6,100,000 | $3,200,000 |